NCT02094534
A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics
Phase: Phase 2
Role: Collaborator
Start: Mar 31, 2014
Completion: Oct 31, 2014